SkinbiotherapeuticsSBTX 
$0.13-0.94%24h
-0.94%24h
Global rank
Market cap$21.67M
Change 7d-14.95%
YTD Performance-30.98%
SP500 benchmarkUnderperform
P/E-7.65
P/S131.28
Revenue$165.04K
Earnings-$3.54M
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Skinbiotherapeutics (SBTX)
As of December 2024, Skinbiotherapeutics has a market cap of $21.67M. This makes Skinbiotherapeutics the world's th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Skinbiotherapeutics from 2017 to 2024
-
Value:-
Market cap history of Skinbiotherapeutics from 2017 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $22.13M | -29.51% |
| 2023 | $31.39M | -1.61% |
| 2022 | $31.91M | -63.10% |
| 2021 | $86.46M | 78.72% |
| 2020 | $48.38M | 62.50% |
| 2019 | $29.77M | 7.41% |
| 2018 | $27.72M | 47.95% |
| 2017 | $18.73M | - |
SBTX Market Cap Today is $21.67M -0.94% - 20 Dec 2024
View largest stocks by market cap 
